Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Humanized anti-VEGF antibody fragment proves effective in wet AMD

Oct. 4, 2002

No Comments

Phase I/II results for INS-37217 in rhegmatogenous retinal detachment

Oct. 4, 2002

No Comments

Twelve-month data show efficacy of anecortave acetate in wet AMD

Oct. 2, 2002

No Comments

ISV-401 safe and effective in acute bacterial conjunctivitis

Oct. 1, 2002

No Comments

New phase III study for anecortave acetate in AMD

Sep. 5, 2002

No Comments

Compounds for glaucoma and ocular hypertension with improved profile over natural prostaglandins

Sep. 4, 2002

No Comments

E.U. approval for Visudyne

Sep. 2, 2002

No Comments

Subanalysis of SnET2 phase III data

Aug. 29, 2002

No Comments

Clinical trial commences for squalamine in treatment of AMD

Aug. 23, 2002

No Comments

VitrenASE enters phase II trial in proliferative vitreoretinopathy

Aug. 21, 2002

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Humanized anti-VEGF antibody fragment proves effective in wet AMD

Phase I/II results for INS-37217 in rhegmatogenous retinal detachment

Twelve-month data show efficacy of anecortave acetate in wet AMD

ISV-401 safe and effective in acute bacterial conjunctivitis

New phase III study for anecortave acetate in AMD

Compounds for glaucoma and ocular hypertension with improved profile over natural prostaglandins

E.U. approval for Visudyne

Subanalysis of SnET2 phase III data

Clinical trial commences for squalamine in treatment of AMD

VitrenASE enters phase II trial in proliferative vitreoretinopathy

Today's news in brief

Today's news in brief

Boryung invests $10M in Intuitive Machines for outer space R&D

Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal

Phase II Huntington’s tie-up with Novartis could edge $3B for PTC

Ocular RSS

Ocular
RSS